Thailand - Delayed Quote THB

Praram 9 Hospital Public Company Limited (PR9.BK)

Compare
25.50
+0.25
+(0.99%)
At close: 4:38:29 PM GMT+7
Loading Chart for PR9.BK
DELL
  • Previous Close 25.25
  • Open 25.25
  • Bid 25.75 x --
  • Ask 26.00 x --
  • Day's Range 24.60 - 26.00
  • 52 Week Range 16.80 - 27.50
  • Volume 7,398,504
  • Avg. Volume 2,408,801
  • Market Cap (intraday) 20.051B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 28.98
  • EPS (TTM) 0.88
  • Earnings Date Feb 18, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 0.45 (1.78%)
  • Ex-Dividend Date Nov 22, 2024
  • 1y Target Est 29.31

Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as breast, and vaccination and travel medicine clinics. It is also involved in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes. Praram 9 Hospital Public Company Limited was founded in 1992 and is based in Bangkok, Thailand.

www.praram9.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PR9.BK

View More

Performance Overview: PR9.BK

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

PR9.BK
4.67%
MSCI WORLD
0.19%

1-Year Return

PR9.BK
58.86%
MSCI WORLD
18.40%

3-Year Return

PR9.BK
147.39%
MSCI WORLD
0.00%

5-Year Return

PR9.BK
236.31%
MSCI WORLD
56.56%

Compare To: PR9.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PR9.BK

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    19.85B

  • Enterprise Value

    17.63B

  • Trailing P/E

    28.69

  • Forward P/E

    24.39

  • PEG Ratio (5yr expected)

    1.41

  • Price/Sales (ttm)

    4.36

  • Price/Book (mrq)

    3.71

  • Enterprise Value/Revenue

    3.87

  • Enterprise Value/EBITDA

    15.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.07%

  • Return on Assets (ttm)

    8.39%

  • Return on Equity (ttm)

    13.57%

  • Revenue (ttm)

    4.61B

  • Net Income Avi to Common (ttm)

    694.15M

  • Diluted EPS (ttm)

    0.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.23B

  • Total Debt/Equity (mrq)

    0.11%

  • Levered Free Cash Flow (ttm)

    627.47M

Research Analysis: PR9.BK

View More

People Also Watch